This study provides a detailed description of the costs of providing outpatient human immunodeficiency virus (HIV) treatment and care in Kenya. The study was conducted as a collaboration between the Kenyan Ministry of Health (MOH) and President’s Emergency Plan for AIDS Relief (PEPFAR) agencies.

The study undertook a retrospective cost analysis at 29 outpatient clinics providing HIV treatment and care, estimating the annual treatment costs for pre-antiretroviral therapy (pre-ART) and ART patients as borne by the Government of Kenya
(MOH), PEPFAR, and other local and international partners. Data were collected to show the cost differences between different patient types, and to show how costs were distributed across funding sources, input types, and programmatic activities over two 6-month periods (January
2010 to December 2010).